Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Viremia
- Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections
- A Study to Evaluate the Antiviral Activity and Safety of HH-003 in Chronic Hepatitis B Subjects With Low-level Viremia
- Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia
- Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation
- Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients: A Non-randomized Cohort Pilot Study
- A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients
- Peginterferon Alpha-2b Therapy in Chronic Hepatitis Patients With Normal ALT Level and Low Viremia
- A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients
- Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients
- Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia
- Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission
- VRC 603: A Phase I Dose-Escalation Study of the Safety of AAV8-VRC07 (VRC-HIVAAV070-00-GT) Recombinant AAV Vector Expressing VRC07 HIV-1 Neutralizing Antibody in Antiretroviral -Treated, HIV-1 Infected Adults With Controlled Viremia.
- Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia.
- CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)
- Emtricitabine/Tenofovir Alafenamide as Salvage ART
- A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable Viremia
- Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients
- Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response
- Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)
- Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Virem
- Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus
- Using mTOR Inhibitors in the Prevention of BK Nephropathy
- An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK Viruria
- Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus
- Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients
- Genotypic Tropism Testing In Proviral Dna To Guide CCR5 Antagonist Treatment In Subjects With Undetectable HIV-1 Viremia
- Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients
- Switching From Protease Inhibitor (PI) to Etravirine in HIV-1 Infected Subjects With Viremia Suppression
- BK Treatment Study
- Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)
- HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
- BK Viremia After Renal Transplantation
- Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
- Pilot Study of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Low Level Viremia
- A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria
- Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection